Pacific Biosciences
PACB
#7750
Rank
C$0.60 B
Marketcap
C$1.96
Share price
2.21%
Change (1 day)
-12.97%
Change (1 year)

Pacific Biosciences (PACB) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$1.10 Billion

According to Pacific Biosciences 's latest financial reports the company's total liabilities are C$1.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$1.06 B-1.42%
2024-12-31C$1.08 B-21.93%
2023-12-31C$1.38 B-15.2%
2022-12-31C$1.63 B5.44%
2021-12-31C$1.54 B1448.47%
2020-12-31C$0.10 B-17.67%
2019-12-31C$0.12 B58.74%
2018-12-31C$76.57 M5.05%
2017-12-31C$72.89 M1.93%
2016-12-31C$71.51 M-10.45%
2015-12-31C$79.85 M-0.9%
2014-12-31C$80.58 M12.98%
2013-12-31C$71.32 M253.32%
2012-12-31C$20.18 M-26.09%
2011-12-31C$27.31 M5.58%
2010-12-31C$25.87 M-91.16%
2009-12-31C$0.29 B16.59%
2008-12-31C$0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
C$86.33 B 7,748.73%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$154.86 B 13,977.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$5.47 B 397.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
C$9.31 B 746.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
C$0.45 B-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA